Oh wow.. how sad. He's proud of more products which are relabelbed current products that don't sell, blames the OTC for a CE that happend because he let the company get behind, re-hashes the DTRA story which is suppose to have been answered by now (no answer is a answer, clearly they aren't excited about it if we're past the deadline) then he throws out clinical garbage, where in a previous PR he states it will begin by years end........I would say buyer beware but the CE speaks volume (or lack of) there. 20 years old, this ain't no startup. This is a cash buying machine with a PROVEN shady CEO